Hello, Fool! | Login | Signup | My Fool
Aug 21, 2008 9:59 PM ET | Site Changes | Help
A biotechnology company focused on the development and commercialization of novel biological therapies for patients with cancer.
View All Commentary (CEGE)
Recs
SavvyPicker (< 20) Submitted: 4/09/07 5:13 PM : Start Price: $7.09 CEGE Score: 49.34
This stock has much to prove in the months (and months) ahead. More specifically, its questionable Phase II results are well documented, along with the onset of more promising competition. Unfortunately, in the wake of disastrous results, investors remain risk-averse as demonstrated by today's irrationsal POP in price.
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.